Fleury S.A. (FLRY3) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Fleury S.A. (FLRY3) has a cash flow conversion efficiency ratio of 0.050x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$264.56 Million ≈ $51.91 Million USD) by net assets (R$5.28 Billion ≈ $1.04 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Fleury S.A. net asset quality index to measure how much of total assets are equity-financed.
Fleury S.A. - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Fleury S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check FLRY3 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Fleury S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fleury S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
JetBlue Airways Corp
NASDAQ:JBLU
|
0.066x |
|
Aerospace Industrial Development Corp
TW:2634
|
0.164x |
|
Beijing Fuxing Xiaocheng Electronic Technology Co Ltd
SHE:300139
|
0.006x |
|
Kansai Nerolac Paints Limited
NSE:KANSAINER
|
0.031x |
|
OFG Bancorp
NYSE:OFG
|
0.028x |
|
Shanghai Weaver Network Co Ltd
SHG:603039
|
0.046x |
|
Henan Lingrui Pharmaceutical Co Ltd
SHG:600285
|
0.038x |
|
Shenzhen Forms Syntron Information Co Ltd
SHE:300468
|
0.070x |
Annual Cash Flow Conversion Efficiency for Fleury S.A. (2006–2025)
The table below shows the annual cash flow conversion efficiency of Fleury S.A. from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Fleury S.A. (FLRY3) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | R$5.10 Billion ≈ $999.98 Million |
R$1.57 Billion ≈ $308.32 Million |
0.308x | -14.16% |
| 2024-12-31 | R$5.37 Billion ≈ $1.05 Billion |
R$1.93 Billion ≈ $378.80 Million |
0.359x | +27.54% |
| 2023-12-31 | R$5.11 Billion ≈ $1.00 Billion |
R$1.44 Billion ≈ $282.42 Million |
0.282x | -22.94% |
| 2022-12-31 | R$2.70 Billion ≈ $530.00 Million |
R$987.13 Million ≈ $193.69 Million |
0.365x | -33.47% |
| 2021-12-31 | R$1.85 Billion ≈ $363.88 Million |
R$1.02 Billion ≈ $199.88 Million |
0.549x | +48.61% |
| 2020-12-31 | R$1.75 Billion ≈ $343.55 Million |
R$647.14 Million ≈ $126.98 Million |
0.370x | -11.22% |
| 2019-12-31 | R$1.76 Billion ≈ $345.14 Million |
R$732.32 Million ≈ $143.69 Million |
0.416x | +3.86% |
| 2018-12-31 | R$1.75 Billion ≈ $343.37 Million |
R$701.49 Million ≈ $137.64 Million |
0.401x | +29.17% |
| 2017-12-31 | R$1.71 Billion ≈ $334.85 Million |
R$529.61 Million ≈ $103.92 Million |
0.310x | -11.67% |
| 2016-12-31 | R$1.54 Billion ≈ $301.34 Million |
R$539.57 Million ≈ $105.87 Million |
0.351x | +57.78% |
| 2015-12-31 | R$1.66 Billion ≈ $324.83 Million |
R$368.63 Million ≈ $72.33 Million |
0.223x | +22.60% |
| 2014-12-31 | R$1.57 Billion ≈ $308.64 Million |
R$285.71 Million ≈ $56.06 Million |
0.182x | +46.38% |
| 2013-12-31 | R$1.69 Billion ≈ $331.42 Million |
R$209.59 Million ≈ $41.12 Million |
0.124x | +26.71% |
| 2012-12-31 | R$1.71 Billion ≈ $334.73 Million |
R$167.05 Million ≈ $32.78 Million |
0.098x | +9.49% |
| 2011-12-31 | R$1.63 Billion ≈ $320.20 Million |
R$145.96 Million ≈ $28.64 Million |
0.089x | -19.86% |
| 2010-12-31 | R$1.01 Billion ≈ $198.53 Million |
R$112.92 Million ≈ $22.16 Million |
0.112x | +289.62% |
| 2009-12-31 | R$838.97 Million ≈ $164.62 Million |
R$24.03 Million ≈ $4.72 Million |
0.029x | -93.99% |
| 2008-12-31 | R$151.84 Million ≈ $29.79 Million |
R$72.40 Million ≈ $14.21 Million |
0.477x | -39.20% |
| 2007-12-31 | R$101.35 Million ≈ $19.89 Million |
R$79.48 Million ≈ $15.60 Million |
0.784x | +16.44% |
| 2006-12-31 | R$105.91 Million ≈ $20.78 Million |
R$71.33 Million ≈ $14.00 Million |
0.673x | -- |
About Fleury S.A.
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and cli… Read more